A Oneindia Venture

Aequs IPO Lists At 13% Premium, Stock Rallies 22% On Exchanges; Should You Buy? Check Live Performance

Aequs IPO Listing: The company has listed at 13% premium on BSE and NSE during December 10 trading session. Overall, the stock zoomed by nearly 22% on exchanges. As per experts, the positive debut indicates upbeat sentiment driven by the company's strong positioning as one of India's most advanced and fully integrated aerospace precision-manufacturing platforms.

Aequs Share Price:

Aequs IPO Lists At 13% Premium, Stock Rallies 22% On Exchanges; Should You Buy?

Aequs listed at 13% premium on BSE and NSE to Rs 140 apiece compared to IPO issue price of Rs 124 apiece.

The stock's 52-week high stood at Rs 151.15 apiece on BSE and Rs 151 on NSE. This leads to an overall upside of nearly 22%.

At the time of writing, Aequs traded at Rs 141.95 apiece on BSE, up by 1.4% from listing price and higher by 14.5% from IPO price.

Also, the stock traded at Rs 142.03 apiece on NSE, registering an upside of 1.5% from listing price and surging by nearly 14.6% from IPO price.

The company's market cap stood more than Rs 9,520 crore.

What Should Investors Do In Aequs Share Price?

As per Shivani Nyati, Head of Wealth at Swastika Investmart, the listing optimism comes on the back of the company's Rs 922-crore IPO, which witnessed exceptional investor demand. The public offer was subscribed 104 times during the three-day bidding window from December 3 to December 5, highlighting strong appetite from institutional as well as retail investors for manufacturing-led growth opportunities within India's expanding aerospace sector.

Despite the moderate listing compared to upper-end expectations, Nyati added, " the sentiment around Aequs remains constructive. The company's ability to scale operations, deepen global customer relationships, and benefit from India's rising prominence in aerospace manufacturing makes it a notable long-term candidate."

However, the expert also added, investors must remain mindful of key risks, including sector cyclicality, dependence on global aerospace demand, and capital-intensive execution.

For investors who received an allotment, the expert suggests a balanced approach. These are:

- Book partial profits after the 13% listing gain to secure immediate returns.

- Hold the remaining quantity for the medium to long term, considering the company's strong fundamentals, industry tailwinds, and its integrated capabilities that differentiate it within India's aerospace ecosystem.

- Traders and short-term investors can consider maintaining a stop-loss near Rs 120 to manage listing-day volatility.

Overall, Nyati said, "Aequs' debut reinforces investor confidence in India's precision-engineering and aerospace manufacturing ambitions, positioning the stock as a potential structural growth story - provided the company executes consistently and maintains operational discipline."

Aequs launched its IPO from December 3rd to December 5th, with issue size of Rs 921.81 crore and price bands ranging from Rs 118 to Rs 124. On the final day of the IPO, Aequs recorded robust oversubscription of 101.63 times.

Disclaimer: The views and recommendations expressed are solely those of the individual analysts or entities and do not reflect the views of Goodreturns.in or Greynium Information Technologies Private Limited (together referred as "we"). We do not guarantee, endorse or take responsibility for the accuracy, completeness or reliability of any content, nor do we provide any investment advice or solicit the purchase or sale of securities. All information is provided for informational and educational purposes only and should be independently verified from licensed financial advisors before making any investment decisions.

Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
  • Block for 8 hours
  • Block for 12 hours
  • Block for 24 hours
  • Don't block
Gender
Select your Gender
  • Male
  • Female
  • Others
Age
Select your Age Range
  • Under 18
  • 18 to 25
  • 26 to 35
  • 36 to 45
  • 45 to 55
  • 55+